Urogen Pharma Ltd(URGN) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing solutions for specialty cancers and urologic diseases. The company's lead product candidates are UGN-101 and UGN-102, which are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-201, a proprietary immunotherapy product candidate for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; and Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery. UroGen Pharma Ltd. was founded in 2004 and is based in Princeton, New Jersey.

Current Price

$17.64

RSI

32.308

Beta:

1.1978

December 31, 2020
-27.7M

13266.071 %
-86.948 %
99.931 %
39.161 %

$11,799,000
$18,000
$1,128,000
$8,158,000
$17,530,000
$0
65450.000 %
-98.404 %
-86.173 %
-53.463 %
0.000 %

$-125,110,000
$-82,802,000
$-75,532,000
$-19,981,000
$-1,941,000
$-12,689,000
-51.095 %
-9.625 %
-278.019 %
-929.418 %
84.703 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.